Statin Use and Incident Heart Failure by Race and Cardiovascular Disease Risk in a Real World Primary Prevention Cohort

被引：0
|
作者：
Hay, Eli J.
Zhu, Jianhui
Thoma, Floyd W.
Marroquin, Oscar C.
Muluk, Pallavi
Johnson, Amber E.
Countouris, Malamo E.
Smith, Anson J.
Saeed, Gul J.
Al Rifai, Mahmoud
Saeed, Anum
Mulukutla, Suresh R.
机构：
来源：
CIRCULATION | 2022年 / 146卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
A14412
引用
收藏
页数：3
相关论文
共 50 条
  • [41] LOW ATHEROGENIC LIPOPROTEINS & INCIDENT ATHEROSCLEROTIC CARDIOVASCULAR DISEASE: A POOLED COHORT PRIMARY PREVENTION STUDY
    Faridi, Kamil
    Quispe, Renato
    Martin, Seth Shay
    Jones, Steven R.
    Blumenthal, Roger S.
    Saeed, Anum
    Lima, Joao A. C.
    Spatz, Erica Sarah
    Rana, Jamal S.
    Michos, Erin D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2024, 83 (13) : 1943 - 1943
  • [42] Use of statin for the primary prevention of cardiovascular outcomes in elderly patients: A propensity-matched cohort study
    Cho, Yongin
    Jeong, Yujin
    Seo, Da Hea
    Ahn, Seong Hee
    Hong, Seongbin
    Suh, Young Ju
    Kim, So Hun
    ATHEROSCLEROSIS, 2021, 328 : 92 - 99
  • [43] C-Reactive Protein and Risk of Incident Heart Failure in Patients With Cardiovascular Disease
    Burger, Pascal M.
    Koudstaal, Stefan
    Mosterd, Arend
    Fiolet, Aernoud T. L.
    Teraa, Martin
    van der Meer, Manon G.
    Cramer, Maarten J.
    Visseren, Frank L. J.
    Ridker, Paul M.
    Dorresteijn, Jannick A. N.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 82 (05) : 414 - 426
  • [44] Age, Statin Use, and the Risk for Incident Parkinson Disease reply
    Gao, Xiang
    Simon, Kelly C.
    Schwarzschild, Michael A.
    Ascherio, Alberto
    ARCHIVES OF NEUROLOGY, 2012, 69 (10) : 1381 - 1381
  • [45] Comparison of 3 risk estimators to guide initiation of statin therapy for primary prevention of cardiovascular disease
    Ofori, Sandra
    Dodiyi-Manuel, Sotonye
    Akpa, Maclean R.
    JOURNAL OF CLINICAL LIPIDOLOGY, 2017, 11 (06) : 1441 - 1447
  • [46] Prevalence of Statin Use for Primary Prevention of Cardiovascular Disease in US Veterans ≥65: 2002 and 2012
    Orkaby, A. R.
    Vetter, J.
    Kurgansky, K.
    Cho, K.
    Gagnon, D.
    Gaziano, J. M.
    Driver, J. A.
    Djousse, L.
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2019, 67 : S54 - S54
  • [47] Trends in Statin Use for Primary Prevention by Race/Ethnicity and ASCVD Risk in the US: 2013-2020
    Jacobs, Joshua A.
    Addo, Daniel K.
    Zheutlin, Alexander R.
    Derington, Catherine G.
    Essien, Utibe R.
    Navar, Ann M.
    Hernandez, Inmaculada
    Lloyd-Jones, Donald M.
    King, Jordan B.
    Rao, Shreya
    Herrick, Jennifer S.
    Bress, Adam P.
    Pandey, Ambarish
    CIRCULATION, 2022, 146
  • [48] Diabetes treatments and risk of heart failure, cardiovascular disease, and all cause mortality: cohort study in primary care
    Hippisley-Cox, Julia
    Coupland, Carol
    BMJ-BRITISH MEDICAL JOURNAL, 2016, 354
  • [49] Predictors of incident heart failure in a cohort of patients with ischemic heart disease
    Abdissa, Senbeta Guteta
    PAN AFRICAN MEDICAL JOURNAL, 2020, 35
  • [50] Atherosclerotic Cardiovascular Disease in Psoriatic Arthritis: Evaluation of Risk Factor Management and Use of Aspirin and Statin for Prevention in a Primary Care Setting
    Linh Truong
    Ridolfi, Nicole
    Wong, Maida
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
12345